^
Association details:
Biomarker:No biomarker
Cancer:Gastrointestinal Stromal Tumor
Drug:Iclusig (ponatinib) (Multi-tyrosine kinase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
03/13/2023
Excerpt:
Gastrointestinal Stromal Tumors….Systemic Therapy Agents and Regimens for Unresectable, Progressive or Metastatic Disease….Ponatinib, Useful in certain circumstances